Wockhardt Ltd.
Snapshot View

256.35 -1.65 ▼-0.6%

23 September 2022, 04:01:00 PM
Volume: 47,733

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.wockhardt.com
Market Cap 3,692.98 Cr.
Enterprise Value(EV) 5,148.98 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -20.70 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share 260.73 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.98 Calculated using Price: 256.35
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 14.41 Cr. 144,060,154 Shares
FaceValue 5
Company Profile
The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.64%
1 Week
-0.56%
1 Month
+0.23%
3 Month
+15.53%
6 Month
-17.69%
1 Year
-35.76%
2 Year
+0.05%
5 Year
-54.68%
10 Year
-77.65%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.04 12.49 7.07 -6.42 -21.81 -11.43 -1.64 -9.92 -7.77
Return on Capital Employed (%) 18.98 11.25 6.87 -0.31 -5.47 -2.87 1.32 -5.50 -1.96
Return on Assets (%) 13.36 5.84 3.25 -2.69 -7.93 -4.01 -0.57 -3.93 -3.71

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2,704 3,581 3,715 3,775 3,337 2,852 2,675 2,672 3,376 3,849
Non Curr. Liab. 1,521 1,161 1,872 1,893 3,151 2,089 1,703 1,195 496 261
Curr. Liab. 1,773 1,743 1,773 1,842 1,979 2,692 2,864 3,497 3,121 3,207
Minority Int. 136 144 465 382 346 330 386 383 353
Equity & Liab. 5,998 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670
Non Curr. Assets 2,672 3,266 3,983 4,024 4,314 4,599 4,756 5,320 4,951 5,081
Curr. Assets 3,327 3,356 3,522 3,952 4,535 3,380 2,815 2,430 2,425 2,589
Misc. Exp. not W/O
Total Assets 5,998 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 4,830 4,482 4,453 4,015 3,937 3,566 3,325 2,708 3,230 2,966
Other Income 38 67 66 101 120 21 60 132 20 78
Total Income 4,869 4,548 4,519 4,115 4,057 3,587 3,385 2,840 3,250 3,044
Total Expenditure -3,805 -3,772 -3,959 -3,988 -3,935 -3,604 -3,082 -2,771 -2,932 -2,808
PBIDT 1,064 776 560 127 122 -17 303 69 318 237
Interest -83 -55 -129 -225 -255 -265 -276 -249 -299 -308
Depreciation -140 -145 -142 -149 -150 -164 -224 -246 -247 -246
Taxation -48 -163 -38 21 -26 135 153 271 132 154
Exceptional Items 50 -358 -142 -183 -183
PAT 843 413 252 -226 -667 -312 -43 -297 -279 -347
Minority Interest -2 -8 -2 30 59 22 -26 -2 35 49
Share Associate 0 1
Other Related Items -139
Consolidated Net Profit 702 405 251 -196 -608 -195 -69 686 -244 -298
Adjusted EPS 59 34 21 -16 -51 -16 -6 57 -17 -20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,532 1,476 355 72 -269 68 183 649 -287 413
Cash Fr. Inv. 1,085 -852 -207 -818 -687 630 95 -156 1,470 -201
Cash Fr. Finan. -2,246 -601 -76 254 1,254 -769 -776 -680 -1,171 -71
Net Change 372 23 73 -492 298 -71 -499 -186 12 141
Cash & Cash Eqvt 1,050 1,102 1,159 665 964 897 397 219 232 370

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 72.13 72.12 72.12 72.12 69.68 68.04 67.13 67.13 65.75
Public 27.87 27.88 27.88 27.88 30.32 31.96 32.87 32.87 34.25
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 26.42 22.41 10.14 18.71 34.44 41.99 47.32 43.60 47.84

Announcements View Details >>

Thu, 22 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations)
Thu, 08 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SBICAP Trustee Company Ltd
Mon, 05 Sep 2022
Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmation of Credit Rating

Technical Scans View Details >>

Fri, 23 Sep 2022
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
5 SMA Crossing 20 SMA From Above 5 SMA Crossing 20 SMA From Above
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Wockhardt Ltd.

What is Wockhardt share price?

Can I buy Wockhardt shares now?

What is the Market Cap of Wockhardt?

What are the key metrics to analyse Wockhardt?

What is the 52 Week High and Low of Wockhardt?

What is the trend of Wockhardt share price?